Millionaire Investors Prefer Harris To Trump, UBS Poll Says
But in an accompanying survey, 500 owners of businesses with annual revenues above $1 million leaned toward Trump, favoring his tax proposals.
Trump vs. Harris: Who is ahead in the presidential race? Here's what polls say
Will Former President Donald Trump secure a second term or will Vice President Kamala Harris become the first female president?
Donald Trump's Chances of Beating Kamala Harris in Wisconsin: Polls
The race for Wisconsin remains incredibly close between former President Donald Trump and Vice President Kamala Harris, with one poll released this week finding the candidates tied in the critical battleground state.
Harris Gains Edge Over Trump on Economy in New Swing State Poll
Trump has had a consistent lead when it comes to the question of who voters trust on the economy — but Harris is narrowing the gap.
How Donald Trump and Kamala Harris are polling in swing states
Who will win the race to the White House? Here are presidential polling averages in seven battleground states as of Sept. 26.
Fox News Poll: Harris is ahead of Trump by 3 points in Georgia
In a head-to-head matchup, Vice President Kamala Harris tops former President Donald Trump by three percentage points in a Fox News survey of Georgia voters.
A majority of millionaires plan to vote for Harris over Trump in November
A new UBS survey shows 57% of investors with at least $1 million in investable assets support Harris, while 43% back Trump.
Most investors mull portfolio changes ahead of US election, UBS survey shows
Most wealthy investors are considering changes in their portfolios ahead of the Nov. 5 U.S. presidential election, according ...
Mexico’s Peso to Gain as Political Uncertainty Ebbs, UBS Says
Mexico’s peso is set to strengthen through the first half of next year as investors grow more comfortable with the new ...
UBS Downgrades GE HealthCare Technologies (BVC:GEHC)
Fintel reports that on September 26, 2024, UBS downgraded their outlook for GE HealthCare Technologies ( BVC:GEHC) from ...
UBS ahead of schedule on cost savings, CEO says
Swiss bank UBS is running around six months ahead of schedule in its cost savings efforts and its integration of Credit ...
Sun Pharma rallies 3%; hits new high on UBS 'Buy' rating, sees more upside
UBS has a target price of Rs 2,450 on Sun Pharma and expects it to record the highest growth in the near-term and the ...
UBS initiates 'sell' call on slew of pharma majors; sees growth slowdown in India & US mkts
UBS initiated 'sell' calls on Dr Reddy's Laboratories Lupin, Aurobindo Pharma and Zydus Lifesciences while picking Sun Pharma ...
If there’s a nuclear renaissance, here are the stocks to watch, says UBS
It’s a great morning for everything connected to China — not just Chinese stocks but also commodities, luxury-goods makers ...
finews59m
Private Bank Recruits Prominent UBS Team
Pictet expands its Zurich Private Banking Unit by adding four UBS specialists to the Leuenhof. This is a major loss for the combined Megabank.
Miami Tops UBS Property Bubble Risk as Global Imbalances Decline
US cities including Miami and Boston are seeing high or rising risk of bubbles forming in their real estate markets even as ...
Pay on Results PR Recognised as One of the Fastest Growing Businesses in the UK in UBS-supported Fast Growth Index 2024
Pay on Results PR is proud to announce its inclusion in the prestigious UK Fast Growth Index for 2024, supported by ...
UBS Sticks to Their Buy Rating for Visa (V)
UBS analyst Timothy Chiodo maintained a Buy rating on Visa (V – Research Report) today and set a price target of $320.00. The ...